Latest News and Press Releases

GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty...

Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan...

TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...

GRENOBLE, France, March 20, 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a global leader and innovator in urology and prostate care, announced today it is...

Primo partners with ABX to bring PB01 to Taiwan, enhancing prostate cancer diagnosis with PSMA PET imaging, leveraging Radelumin’s success in Europe.

Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Oncology Market Industry Trends and Global Forecasts to 2035, by Type of Cancer, Type of End-Users and Key Geographical...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, localized prostate cancerRecently announced positive final...

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The...

Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal...

GAITHERSBURG, Md., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty...